IonQ, Inc. 8-K
Research Summary
AI-generated summary
IonQ, Inc. Files Prospectus Supplement for Resale of 5.13M Shares
What Happened
IonQ, Inc. announced on February 27, 2026 that it filed a prospectus supplement with the SEC to the Form S-3ASR registration statement (File No. 333-285279) allowing certain selling stockholders to resell an aggregate of 5,127,459 shares of the Company’s common stock (par value $0.0001). The filing includes a legal opinion from Paul, Weiss, Rifkind, Wharton & Garrison LLP, which is attached as Exhibit 5.1 and incorporated by reference into the registration statement. The Form 8-K was signed by Paul T. Dacier, Chief Legal Officer and Corporate Secretary.
Key Details
- 5,127,459 shares of IonQ common stock covered by the prospectus supplement.
- Common stock par value: $0.0001 per share.
- Prospectus supplement amends the Company’s Form S-3ASR registration statement filed February 26, 2025 (File No. 333-285279).
- Legal opinion of Paul, Weiss is filed as Exhibit 5.1; the firm’s consent is included and referenced.
Why It Matters
This filing makes up to 5.13 million existing IonQ shares available for public resale by the named selling stockholders, which can affect the number of shares available in the market (liquidity and supply). The included legal opinion supports the registration mechanics for those resales. Investors should watch subsequent disclosures for which holders are selling and any planned timing, as such resale registrations can influence trading volume and share availability.